AstraZeneca Settles Seroquel Suits For A Third Of What Lilly Paid For Zyprexa

In deciding to settle rather than continue to litigate Seroquel (quetiapine) product liability claims, AstraZeneca is following the path Lilly took in resolving suits over its antipsychotic Zyprexa (olanzapine). But the financial burden won't be as heavy for AstraZeneca

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet